Real-time enrollment status for this adpkd (autosomal dominant polycystic kidney disease) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 5:28 PM UTC
| NCT Number | NCT07282821 |
| Recruiting Status | Recruiting |
| Condition | ADPKD (Autosomal Dominant Polycystic Kidney Disease) |
| Phase | PHASE2 |
| Target Enrollment | 120 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Kenneth Hallows |
| Last Updated on CT.gov | September 29, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT07282821 is currently recruiting participants. This phase2 study for adpkd (autosomal dominant polycystic kidney disease) is actively seeking new participants at 3 locations across the United States. The study is sponsored by Kenneth Hallows. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07282821 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07282821 was last updated 1 week ago (September 29, 2026). HelloStudys verifies this status automatically.